Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting
作者： Donald C. Moore , Justin R. Arnall , Dragos C. Plesca
DOI: 10.2146/AJHP180060
关键词:
摘要: With an increasing focus on patient-centric delivery of care and growing financial constraints healthcare, several common oncology chemotherapy regimens traditionally administered in the inpatient setting have been considered evaluated ambulatory setting. Although most solid
oup.com
ajhp.org参考文章(34)
Marcello Tiseo, Olga Martelli, Andrea Mancuso, Maria Pia Sormani, Paolo Bruzzi, Roberto Di Salvia, Filippo De Marinis, Andrea Ardizzoni, Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma. Tumori. ,vol. 93, pp. 138- 144 ,(2007) , 10.1177/030089160709300205
Patrick T. Griffin, Viet Q. Ho, William Fulp, Taiga Nishihori, Kenneth H. Shain, Melissa Alsina, Rachid C. Baz, A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma Cancer. ,vol. 121, pp. 3622- 3630 ,(2015) , 10.1002/CNCR.29533
N. FURUKAWA, R. KAWAGUCHI, H. KOBAYASHI, Use of high-dose cisplatin with aprepitant in an outpatient setting. European Journal of Cancer Care. ,vol. 21, pp. 436- 441 ,(2012) , 10.1111/J.1365-2354.2011.01284.X
Craig H. Moskowitz, Joseph R. Bertino, Jill R. Glassman, Eric E. Hedrick, Sonia Hunte, Nancy Coady-Lyons, David B. Agus, Andre Goy, Joseph Jurcic, Ariela Noy, James O'Brien, Carol S. Portlock, David S. Straus, Barrett Childs, Richard Frank, Joachim Yahalom, Daniel Filippa, Diane Louie, Stephen D. Nimer, Andrew D. Zelenetz, Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma Journal of Clinical Oncology. ,vol. 17, pp. 3776- 3785 ,(1999) , 10.1200/JCO.1999.17.12.3776
W H Wilson, G Bryant, S Bates, A Fojo, R E Wittes, S M Steinberg, D R Kohler, E S Jaffe, J Herdt, B D Cheson, EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. Journal of Clinical Oncology. ,vol. 11, pp. 1573- 1582 ,(1993) , 10.1200/JCO.1993.11.8.1573
Alina S. Gerrie, Joseph R. Mikhael, Lu Cheng, Haiyan Jiang, Vishal Kukreti, Tony Panzarella, Donna Reece, Keith A. Stewart, Young Trieu, Suzanne Trudel, Christine I. Chen, D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma British Journal of Haematology. ,vol. 161, pp. 802- 810 ,(2013) , 10.1111/BJH.12325
Kieron Dunleavy, Stefania Pittaluga, Lauren S. Maeda, Ranjana Advani, Clara C. Chen, Julie Hessler, Seth M. Steinberg, Cliona Grant, George Wright, Gaurav Varma, Louis M. Staudt, Elaine S. Jaffe, Wyndham H. Wilson, Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma The New England Journal of Medicine. ,vol. 368, pp. 1408- 1416 ,(2013) , 10.1056/NEJMOA1214561
Choon-Kee Lee, Bart Barlogie, Nikhil Munshi, Maurizio Zangari, Athanasios Fassas, Joth Jacobson, Frits van Rhee, Michele Cottler-Fox, Firas Muwalla, Guido Tricot, DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma Journal of Clinical Oncology. ,vol. 21, pp. 2732- 2739 ,(2003) , 10.1200/JCO.2003.01.055
Tom Møller, Ove Juul Nielsen, Pernille Welinder, Anne Dünweber, Maiken Hjerming, Claus Moser, Lars Kjeldsen, Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemia. European Journal of Haematology. ,vol. 84, pp. 316- 322 ,(2010) , 10.1111/J.1600-0609.2009.01397.X
Lalit Saini, Mark D. Minden, Andre C. Schuh, Karen W.L. Yee, Aaron D. Schimmer, Vikas Gupta, Eshetu G. Atenafu, Cindy Murray, Shannon Nixon, Joseph M. Brandwein, Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia. American Journal of Hematology. ,vol. 87, pp. 323- 326 ,(2012) , 10.1002/AJH.22268